ofloxacin has been researched along with Urethritis in 42 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Urethritis: Inflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this multicenter, double-blind trial, 625 patients (270 men, 355 women) with uncomplicated gonococcal urethritis or cervicitis received one 100-mg tablet of trovafloxacin or two 200-mg capsules of ofloxacin as a single dose under direct supervision." | 9.08 | Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group. ( Dalu, ZA; Johnson, RB; Jones, RB; Leone, P; Schwebke, J; Thorpe, EM, 1998) |
| "Fifty-eight males and 34 females with nongonococcal urethritis and/or cervicitis were treated to compare the efficacy and safety of 7-day regimens of oral ofloxacin 300 mg twice daily and doxycycline hyclate 100 mg twice daily." | 9.06 | Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis. ( Beville, R; Holmes, B; Lutz, FB; Mogabgab, WJ; Murray, M; Tack, KJ, 1990) |
| "The efficacy of ofloxacin was compared with that of doxycycline in the treatment of non-gonococcal urethritis (NGU) and cervical chlamydial infection in an open randomized study." | 9.06 | Comparison of ofloxacin with doxycycline in the treatment of non-gonococcal urethritis and cervical chlamydial infection. ( Donegan, C; Harris, JR; Kitchen, VS; Taylor-Robinson, D; Thomas, B; Ward, H, 1990) |
| "Efficacy and safety of ofloxacin (OFLX), a new quinolone antibacterial agent, were investigated in cases of sexually transmitted male urethritis and cervicitis." | 9.06 | [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis]. ( Aso, Y; Higashihara, E; Hirose, T; Kishi, H; Kiyota, H; Kumamoto, Y; Machida, T; Okazaki, T; Sakai, S; Tsunekawa, T, 1988) |
| "The efficacy of ofloxacin, a new quinolone derivate, was tested against that of erythromycin in a prospective double-blind trial in patients with non-gonococcal urethritis (NGU) with special reference to the occurrence of Mycoplasma hominis and Ureaplasma urealyticum." | 9.06 | Occurrence of Ureaplasma urealyticus and Mycoplasma hominis in non-gonococcal urethritis before and after treatment in a double-blind trial of ofloxacin versus erythromycin. ( From, E; Halkier-Sørensen, L; Herrmann, B; Ibsen, HH; Mårdh, PA; Møller, BR, 1990) |
| " trachomatis urethritis were treated for five days with 2 X 200 mg ofloxacin." | 9.06 | Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis. ( Bischoff, W, 1986) |
| "We investigated the efficacy and safety of levofloxacin (LVFX) 500mg once a day in patients with non-gonorrheal urethritis." | 7.78 | [Efficacy and safety of levofloxacin to non-gonorrheal urethritis]. ( Hosobe, T; Kato, T; Onodera, S; Onoe, Y; Yoshida, M, 2012) |
| "To confirm the efficacy of the treatment regimen with oral levofloxacin (LVFX) 500 mg once daily for 7 days for patients with non-gonococcal urethritis (NGU), we evaluated the microbiological and clinical outcomes of the regimen in those patients." | 7.77 | Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. ( Hashimoto, J; Hayashi, K; Ichihara, K; Iwasawa, A; Kurimura, Y; Satoh, T; Sunaoshi, K; Suzuki, N; Takahashi, S; Takeda, K; Tsukamoto, T, 2011) |
| "We performed basic and clinical studies in male gonococcal urethritis on a new oral antimicrobial agent, levofloxacin (LVFX, DR-3355), a new quinolone derivative." | 7.68 | [Bacteriological and clinical studies on levofloxacin in male gonococcal urethritis]. ( Ono, K; Saiko, Y; Saito, I; Suzuki, A; Yokozawa, M, 1992) |
| "Clinical effects of ofloxacin (OFLX) in the treatment of chlamydial urethritis was compared with those in the treatment of non-chlamydial urethritis." | 7.67 | [Treatment of nongonococcal urethritis--studies on clinical effects of ofloxacin]. ( Kunisawa, Y; Saito, I; Terada, Y, 1986) |
| "Ofloxacin is a new fluoroquinolone with in vitro activity against the three main urethritis-causing pathogens: i." | 7.67 | [Treatment with ofloxacin (RU 43280) of uncomplicated bacterial urethritis in males]. ( Bianchi, A; Casin, I; Dolivo, M; Morel, P; Perol, Y, 1986) |
| "Clinical effects of ofloxacin (OFLX) in the treatment of the patients with chlamydial urethritis was studied." | 7.67 | [Treatment of chlamydial urethritis--studies on clinical effects of ofloxacin]. ( Asano, H; Fujita, T; Hasegawa, S; Hattori, R; Hibi, H; Kinukawa, T; Matsui, M; Matuura, O; Ohshima, S; Takeuchi, N, 1989) |
| "A multi-institutional clinical study was performed on the efficacy of Ofloxacin against chlamydial urethritis in males between January and June, 1987." | 7.67 | [Studies of clinical efficacy of ofloxacin against male urethritis caused by Chlamydia trachomatis]. ( Matsuda, T; Okada, K; Yoshida, O, 1988) |
| "The efficacy of ofloxacin was evaluated in 30 men with non-gonococcal urethritis (NGU) and 17 women with Chlamydia trachomatis infection of the cervix." | 7.67 | Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women. ( Nayagam, AT; Oriel, JD; Ridgway, GL, 1988) |
| "The effect of Ofloxacin administered orally 600 mg everyday for 14 days was evaluated in 20 male patients with Chlamydial urethritis, in whom Chlamydia was identified from urethral secretion by immunohistochemical technique using monoclonal primary antibody specific for all known serotypes of Chlamydia trachomatis and psittaci." | 7.67 | [Ofloxacin for the treatment of chlamydial urethritis]. ( Araki, H; Azuma, Y; Kitamori, T; Terasaki, T; Watanabe, H; Yuri, K, 1988) |
| " In a multicenter study in seven Asian countries, 105 mal patients with chlamydial urethritis and 46 male patients with nongonococcal and nonchlamydial urethritis were treated with oral ofloxacin at a dosage of 200 mg twice daily for 5 to 10 days." | 6.67 | Ofloxacin treatment of nongonococcal urethritis. A multi-center study in Asia. ( Chang, LS; Daili, SF; Kawada, Y; Lai, C; Lee, JM; Limson, BM; Polnikorn, N; Saito, I, 1990) |
| "Ofloxacin is a new fluoroquinolone with excellent in vitro activity against N." | 5.27 | [One-dose treatment of male gonococcal urethritis by ofloxacin]. ( Baury, A; Casin, I; Lassau, F; Morel, P; Perol, Y, 1987) |
| "In this multicenter, double-blind trial, 625 patients (270 men, 355 women) with uncomplicated gonococcal urethritis or cervicitis received one 100-mg tablet of trovafloxacin or two 200-mg capsules of ofloxacin as a single dose under direct supervision." | 5.08 | Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group. ( Dalu, ZA; Johnson, RB; Jones, RB; Leone, P; Schwebke, J; Thorpe, EM, 1998) |
| "The efficacy of ofloxacin, a new quinolone derivate, was tested against that of erythromycin in a prospective double-blind trial in patients with non-gonococcal urethritis (NGU) with special reference to the occurrence of Mycoplasma hominis and Ureaplasma urealyticum." | 5.06 | Occurrence of Ureaplasma urealyticus and Mycoplasma hominis in non-gonococcal urethritis before and after treatment in a double-blind trial of ofloxacin versus erythromycin. ( From, E; Halkier-Sørensen, L; Herrmann, B; Ibsen, HH; Mårdh, PA; Møller, BR, 1990) |
| "The efficacy of ofloxacin was compared with that of doxycycline in the treatment of non-gonococcal urethritis (NGU) and cervical chlamydial infection in an open randomized study." | 5.06 | Comparison of ofloxacin with doxycycline in the treatment of non-gonococcal urethritis and cervical chlamydial infection. ( Donegan, C; Harris, JR; Kitchen, VS; Taylor-Robinson, D; Thomas, B; Ward, H, 1990) |
| "Fifty-eight males and 34 females with nongonococcal urethritis and/or cervicitis were treated to compare the efficacy and safety of 7-day regimens of oral ofloxacin 300 mg twice daily and doxycycline hyclate 100 mg twice daily." | 5.06 | Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis. ( Beville, R; Holmes, B; Lutz, FB; Mogabgab, WJ; Murray, M; Tack, KJ, 1990) |
| "This study compared doxycycline with ofloxacin in the treatment of nongonococcal urethritis in men and mucopurulent cervicitis in women and compared both drugs in the treatment of infections due to Chlamydia trachomatis in both men and women." | 5.06 | Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease. ( Batteiger, BE; Jones, RB; White, A, 1989) |
| "The clinical efficacies of 2 different single-dose oral treatments of ofloxacin were evaluated in a double-blind, randomised study of 60 males with gonococcal urethritis." | 5.06 | Single doses of ofloxacin in uncomplicated gonorrhoea. ( Aznar, J; Herrera, A; Perea, EJ; Prados, R; Rodriguez-Pichardo, A, 1987) |
| "Efficacy and safety of ofloxacin (OFLX), a new quinolone antibacterial agent, were investigated in cases of sexually transmitted male urethritis and cervicitis." | 5.06 | [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis]. ( Aso, Y; Higashihara, E; Hirose, T; Kishi, H; Kiyota, H; Kumamoto, Y; Machida, T; Okazaki, T; Sakai, S; Tsunekawa, T, 1988) |
| " trachomatis urethritis were treated for five days with 2 X 200 mg ofloxacin." | 5.06 | Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis. ( Bischoff, W, 1986) |
| "We investigated the efficacy and safety of levofloxacin (LVFX) 500mg once a day in patients with non-gonorrheal urethritis." | 3.78 | [Efficacy and safety of levofloxacin to non-gonorrheal urethritis]. ( Hosobe, T; Kato, T; Onodera, S; Onoe, Y; Yoshida, M, 2012) |
| "To confirm the efficacy of the treatment regimen with oral levofloxacin (LVFX) 500 mg once daily for 7 days for patients with non-gonococcal urethritis (NGU), we evaluated the microbiological and clinical outcomes of the regimen in those patients." | 3.77 | Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. ( Hashimoto, J; Hayashi, K; Ichihara, K; Iwasawa, A; Kurimura, Y; Satoh, T; Sunaoshi, K; Suzuki, N; Takahashi, S; Takeda, K; Tsukamoto, T, 2011) |
| " A few days before he had been treated with ciprofloxacine 500mg bid for chlamydial urethritis." | 3.74 | [Fluorquinolone associated tendon rupture]. ( Bürr, P; Haschke, M; Rätz Bravo, A; Stoll, R, 2008) |
| " All 19 cases of gonoccocal urethritis in the present study were cured with a single intramuscular injection of 2 g spectinomycin." | 3.72 | Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002. ( Abe, H; Aoto, T; Nishimura, T; Norose, Y; Ohkuni, H; Ohzuka, H, 2003) |
| "In this study, 72 men with nongonococcal urethritis were treated with levofloxacin." | 3.71 | Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis. ( Deguchi, T; Ishiko, H; Kojima, K; Maeda, SI; Tamaki, M; Yasuda, M; Yoshida, T, 2001) |
| "We performed basic and clinical studies in male gonococcal urethritis on a new oral antimicrobial agent, levofloxacin (LVFX, DR-3355), a new quinolone derivative." | 3.68 | [Bacteriological and clinical studies on levofloxacin in male gonococcal urethritis]. ( Ono, K; Saiko, Y; Saito, I; Suzuki, A; Yokozawa, M, 1992) |
| "Results of the treatment of 5 cases of males with uncomplicated gonoccocal urethritis using levofloxacin (LVFX, DR-3355), the L-type optical isomer of ofloxacin (OFLX), were compared with those treated with OFLX itself." | 3.68 | [Treatment of gonococcal urethritis]. ( Katsukawa, C; Makino, M; Osato, K, 1991) |
| "Clinical effects of ofloxacin (OFLX) in the treatment of the patients with chlamydial urethritis was studied." | 3.67 | [Treatment of chlamydial urethritis--studies on clinical effects of ofloxacin]. ( Asano, H; Fujita, T; Hasegawa, S; Hattori, R; Hibi, H; Kinukawa, T; Matsui, M; Matuura, O; Ohshima, S; Takeuchi, N, 1989) |
| "A multi-institutional clinical study was performed on the efficacy of Ofloxacin against chlamydial urethritis in males between January and June, 1987." | 3.67 | [Studies of clinical efficacy of ofloxacin against male urethritis caused by Chlamydia trachomatis]. ( Matsuda, T; Okada, K; Yoshida, O, 1988) |
| "The effect of Ofloxacin administered orally 600 mg everyday for 14 days was evaluated in 20 male patients with Chlamydial urethritis, in whom Chlamydia was identified from urethral secretion by immunohistochemical technique using monoclonal primary antibody specific for all known serotypes of Chlamydia trachomatis and psittaci." | 3.67 | [Ofloxacin for the treatment of chlamydial urethritis]. ( Araki, H; Azuma, Y; Kitamori, T; Terasaki, T; Watanabe, H; Yuri, K, 1988) |
| "In this study, 20 men suffering from acute nongonococcal epididymitis were treated with ofloxacin 200mg bid given orally for 2 weeks." | 3.67 | Acute nongonococcal epididymitis. Aetiological and therapeutic aspects. ( Garbe, C; Schiefer, HG; Weidner, W, 1987) |
| "Ofloxacin is a new fluoroquinolone with in vitro activity against the three main urethritis-causing pathogens: i." | 3.67 | [Treatment with ofloxacin (RU 43280) of uncomplicated bacterial urethritis in males]. ( Bianchi, A; Casin, I; Dolivo, M; Morel, P; Perol, Y, 1986) |
| "The efficacy of ofloxacin was evaluated in 30 men with non-gonococcal urethritis (NGU) and 17 women with Chlamydia trachomatis infection of the cervix." | 3.67 | Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women. ( Nayagam, AT; Oriel, JD; Ridgway, GL, 1988) |
| "Gonorrhea, trichomoniasis, chlamydiosis and Ureaplasma infection were detected in 60, 31." | 2.67 | [Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases]. ( Bakalova, LA; Bednova, VN; Bugrov, AV; Kisina, VI; Navolotskaia, TI; Vakhnina, TE, 1992) |
| " In a multicenter study in seven Asian countries, 105 mal patients with chlamydial urethritis and 46 male patients with nongonococcal and nonchlamydial urethritis were treated with oral ofloxacin at a dosage of 200 mg twice daily for 5 to 10 days." | 2.67 | Ofloxacin treatment of nongonococcal urethritis. A multi-center study in Asia. ( Chang, LS; Daili, SF; Kawada, Y; Lai, C; Lee, JM; Limson, BM; Polnikorn, N; Saito, I, 1990) |
| "Ofloxacin is a new fluoroquinolone with excellent in vitro activity against N." | 1.27 | [One-dose treatment of male gonococcal urethritis by ofloxacin]. ( Baury, A; Casin, I; Lassau, F; Morel, P; Perol, Y, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (33.33) | 18.7374 |
| 1990's | 15 (35.71) | 18.2507 |
| 2000's | 10 (23.81) | 29.6817 |
| 2010's | 3 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onodera, S | 1 |
| Onoe, Y | 1 |
| Hosobe, T | 1 |
| Kato, T | 1 |
| Yoshida, M | 1 |
| Rätz Bravo, A | 1 |
| Stoll, R | 1 |
| Bürr, P | 1 |
| Haschke, M | 1 |
| Mirone, V | 1 |
| Takahashi, S | 1 |
| Ichihara, K | 1 |
| Hashimoto, J | 1 |
| Kurimura, Y | 1 |
| Iwasawa, A | 1 |
| Hayashi, K | 1 |
| Sunaoshi, K | 1 |
| Takeda, K | 1 |
| Suzuki, N | 1 |
| Satoh, T | 1 |
| Tsukamoto, T | 1 |
| Andreeva, IV | 1 |
| Kozlov, SN | 1 |
| Korolev, SV | 1 |
| Belikov, AN | 1 |
| Grinev, AV | 1 |
| Evstaf'ev, VV | 1 |
| Kirpicheva, NN | 1 |
| Serdiutskaia, MV | 1 |
| Stetsiuk, OU | 1 |
| Fokin, AA | 1 |
| Khrianin, AA | 1 |
| Kanemitsu, N | 1 |
| Hayashi, I | 1 |
| Satoh, N | 1 |
| Hayakawa, T | 1 |
| Mitsuya, H | 1 |
| Hayase, Y | 1 |
| Hiramoto, K | 1 |
| Kojima, M | 1 |
| Abe, H | 1 |
| Nishimura, T | 1 |
| Norose, Y | 1 |
| Aoto, T | 1 |
| Ohzuka, H | 1 |
| Ohkuni, H | 1 |
| Kilic, D | 1 |
| Basar, MM | 1 |
| Kaygusuz, S | 1 |
| Yilmaz, E | 1 |
| Basar, H | 1 |
| Batislam, E | 1 |
| Komeda, H | 1 |
| Fujimoto, Y | 1 |
| Uno, M | 1 |
| Takada, T | 1 |
| Yamada, Y | 1 |
| Yokoi, S | 1 |
| Yasuda, M | 2 |
| Ito, S | 1 |
| Takahashi, Y | 1 |
| Ishihara, S | 1 |
| Deguchi, T | 2 |
| Maeda, S | 1 |
| Kubota, Y | 1 |
| Tamaki, M | 2 |
| Fukushi, H | 1 |
| Yamamoto, Y | 1 |
| Sato, K | 1 |
| Miyazaki, R | 1 |
| Nakai, H | 1 |
| Tanaka, M | 1 |
| Kumazawa, J | 1 |
| Matsumoto, T | 1 |
| Kobayashi, I | 1 |
| Jones, RB | 2 |
| Schwebke, J | 1 |
| Thorpe, EM | 1 |
| Dalu, ZA | 1 |
| Leone, P | 1 |
| Johnson, RB | 1 |
| Kam, KM | 1 |
| Lo, KK | 1 |
| Chong, LY | 1 |
| Au, WF | 1 |
| Wong, PY | 1 |
| Cheung, MM | 1 |
| Somani, J | 1 |
| Bhullar, VB | 1 |
| Workowski, KA | 1 |
| Farshy, CE | 1 |
| Black, CM | 1 |
| Miyashita, N | 1 |
| Matsumoto, A | 1 |
| Matsushima, T | 1 |
| Maeda, SI | 1 |
| Kojima, K | 1 |
| Yoshida, T | 1 |
| Ishiko, H | 1 |
| Bednova, VN | 1 |
| Bakalova, LA | 1 |
| Bugrov, AV | 1 |
| Navolotskaia, TI | 1 |
| Kisina, VI | 1 |
| Vakhnina, TE | 1 |
| Saito, I | 3 |
| Suzuki, A | 1 |
| Saiko, Y | 1 |
| Yokozawa, M | 1 |
| Ono, K | 1 |
| Nakata, S | 1 |
| Miki, M | 1 |
| Okabe, K | 1 |
| Mashimo, T | 1 |
| Kobayashi, M | 1 |
| Yamanaka, H | 1 |
| Takahashi, O | 1 |
| Onuki, T | 1 |
| Battu, V | 1 |
| Arumainayagam, JT | 1 |
| McClean, AN | 1 |
| Osato, K | 1 |
| Katsukawa, C | 1 |
| Makino, M | 1 |
| Kawada, Y | 1 |
| Lee, JM | 1 |
| Lai, C | 1 |
| Chang, LS | 1 |
| Limson, BM | 1 |
| Polnikorn, N | 1 |
| Daili, SF | 1 |
| Møller, BR | 1 |
| Herrmann, B | 1 |
| Ibsen, HH | 1 |
| Halkier-Sørensen, L | 1 |
| From, E | 1 |
| Mårdh, PA | 1 |
| Kitchen, VS | 1 |
| Donegan, C | 1 |
| Ward, H | 1 |
| Thomas, B | 1 |
| Harris, JR | 1 |
| Taylor-Robinson, D | 1 |
| Mogabgab, WJ | 1 |
| Holmes, B | 1 |
| Murray, M | 1 |
| Beville, R | 1 |
| Lutz, FB | 1 |
| Tack, KJ | 1 |
| Batteiger, BE | 1 |
| White, A | 1 |
| Asano, H | 1 |
| Hibi, H | 1 |
| Ohshima, S | 1 |
| Kinukawa, T | 1 |
| Matuura, O | 1 |
| Takeuchi, N | 1 |
| Hattori, R | 1 |
| Hasegawa, S | 1 |
| Fujita, T | 1 |
| Matsui, M | 1 |
| Blomer, R | 1 |
| Bruch, K | 1 |
| Klose, U | 1 |
| Matsuda, T | 1 |
| Okada, K | 1 |
| Yoshida, O | 1 |
| Kumamoto, Y | 1 |
| Sakai, S | 1 |
| Hirose, T | 1 |
| Tsunekawa, T | 1 |
| Machida, T | 1 |
| Kiyota, H | 1 |
| Okazaki, T | 1 |
| Kishi, H | 1 |
| Higashihara, E | 1 |
| Aso, Y | 1 |
| Nayagam, AT | 1 |
| Ridgway, GL | 1 |
| Oriel, JD | 1 |
| Yuri, K | 1 |
| Terasaki, T | 1 |
| Kitamori, T | 1 |
| Azuma, Y | 1 |
| Watanabe, H | 1 |
| Araki, H | 1 |
| Morel, P | 2 |
| Lassau, F | 1 |
| Casin, I | 2 |
| Baury, A | 1 |
| Perol, Y | 2 |
| Aznar, J | 1 |
| Prados, R | 1 |
| Herrera, A | 1 |
| Rodriguez-Pichardo, A | 1 |
| Perea, EJ | 1 |
| Terada, Y | 1 |
| Kunisawa, Y | 1 |
| Weidner, W | 1 |
| Schiefer, HG | 1 |
| Garbe, C | 1 |
| Bianchi, A | 1 |
| Dolivo, M | 1 |
| Bischoff, W | 1 |
1 review available for ofloxacin and Urethritis
| Article | Year |
|---|---|
[From cystitis to bacterial prostatitis: experience with levofloxacin].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cystitis; Double-Blind Method; Drug Therapy, Combinatio | 2009 |
10 trials available for ofloxacin and Urethritis
| Article | Year |
|---|---|
Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group.
Topics: Adolescent; Adult; Anti-Infective Agents; Double-Blind Method; Female; Fluoroquinolones; Gonorrhea; | 1998 |
[Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases].
Topics: Chlamydia Infections; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female | 1992 |
Ofloxacin treatment of nongonococcal urethritis. A multi-center study in Asia.
Topics: Asia; Chlamydia Infections; Chlamydia trachomatis; Humans; Male; Multicenter Studies as Topic; Oflox | 1990 |
Occurrence of Ureaplasma urealyticus and Mycoplasma hominis in non-gonococcal urethritis before and after treatment in a double-blind trial of ofloxacin versus erythromycin.
Topics: Double-Blind Method; Erythromycin; Humans; Male; Mycoplasma; Mycoplasma Infections; Mycoplasmatales | 1990 |
Comparison of ofloxacin with doxycycline in the treatment of non-gonococcal urethritis and cervical chlamydial infection.
Topics: Adolescent; Adult; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Humans; Male; M | 1990 |
Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis.
Topics: Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Humans; Male; Mycoplasmatales Infe | 1990 |
Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease.
Topics: Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Humans; Male; Ofloxacin; Random Al | 1989 |
[Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis].
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Drug Evaluation; Female; Gonorrhea; Humans; Male | 1988 |
Single doses of ofloxacin in uncomplicated gonorrhoea.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Clinical Trials as Topic; Double-Blind Method; Gonor | 1987 |
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Clinical Trials as Topic; | 1986 |
31 other studies available for ofloxacin and Urethritis
| Article | Year |
|---|---|
[Efficacy and safety of levofloxacin to non-gonorrheal urethritis].
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Humans; Levofloxacin; Mal | 2012 |
[Fluorquinolone associated tendon rupture].
Topics: Achilles Tendon; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Bacte | 2008 |
Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Chlamydia Infection | 2011 |
[Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Ceftriaxone; Chl | 2012 |
Acute urethritis caused by Neisseria meningitidis.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Humans; Levofloxacin; Male; Meningococcal Infections; | 2003 |
Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gonorrhea; Huma | 2003 |
Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Topics: Adult; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Dru | 2004 |
[Clinical study of male urethritis in Oogaki Municipal Hospital].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chlamydia Infections; Fluoroquinolones; Gonorrhea; Hospita | 2005 |
Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; DNA Gyrase; | 2004 |
[Clinical studies on DL-8280 in male gonococcal urethritis].
Topics: Adult; Anti-Infective Agents; Drug Evaluation; Gonorrhea; Humans; Male; Middle Aged; Ofloxacin; Oxaz | 1984 |
High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
Topics: Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Microbi | 1994 |
Correlation between in vitro quinolone susceptibility of Neisseria gonorrhoeae and outcome of treatment of gonococcal urethritis with single-dose ofloxacin.
Topics: Adult; Anti-Infective Agents; Cost-Benefit Analysis; Female; Gonorrhea; Humans; In Vitro Techniques; | 1999 |
National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases)
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlortetracycline; | 1999 |
National guideline for the management of gonorrhoea in adults. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Contact Tracing; Female; Gonorrhea; Humans; | 1999 |
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Breast Feeding; Chlamydia Infecti | 1999 |
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Chlamy | 2000 |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithro | 2000 |
Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis.
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; DNA Primers; DNA, Bacterial; Humans; Levofloxacin | 2001 |
[Bacteriological and clinical studies on levofloxacin in male gonococcal urethritis].
Topics: Administration, Oral; Adolescent; Adult; Chlamydia trachomatis; Drug Resistance, Microbial; Gonorrhe | 1992 |
[Clinical analysis of male urethritis].
Topics: Adolescent; Adult; Child; Gonorrhea; Humans; Japan; Lymphogranuloma Venereum; Male; Middle Aged; Min | 1991 |
Comparison of ofloxacin with oxytetracycline in the treatment of non-gonococcal urethritis in men.
Topics: Humans; Male; Ofloxacin; Oxytetracycline; Urethritis | 1991 |
[Treatment of gonococcal urethritis].
Topics: Adult; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Gonorrhea; Humans; Levofloxacin | 1991 |
[Treatment of chlamydial urethritis--studies on clinical effects of ofloxacin].
Topics: Adult; Chlamydia Infections; Drug Evaluation; Humans; Male; Middle Aged; Ofloxacin; Urethritis | 1989 |
Ofloxacin in the treatment of gonococcal and chlamydial urethritis.
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Male; Ofloxacin; Piva | 1988 |
[Studies of clinical efficacy of ofloxacin against male urethritis caused by Chlamydia trachomatis].
Topics: Adult; Aged; Chlamydia Infections; Chlamydia trachomatis; Drug Evaluation; Gonorrhea; Humans; Male; | 1988 |
Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women.
Topics: Adolescent; Adult; Chlamydia Infections; Chlamydia trachomatis; Female; Genital Diseases, Female; Ge | 1988 |
[Ofloxacin for the treatment of chlamydial urethritis].
Topics: Adult; Antigens, Bacterial; Chlamydia Infections; Chlamydia trachomatis; Drug Evaluation; Humans; Im | 1988 |
[One-dose treatment of male gonococcal urethritis by ofloxacin].
Topics: Adult; Anti-Infective Agents; Gonorrhea; Humans; Male; Ofloxacin; Oxazines; Urethritis | 1987 |
[Treatment of nongonococcal urethritis--studies on clinical effects of ofloxacin].
Topics: Adult; Anti-Bacterial Agents; Chlamydia trachomatis; Drug Evaluation; Female; Humans; Male; Middle A | 1986 |
Acute nongonococcal epididymitis. Aetiological and therapeutic aspects.
Topics: Acute Disease; Adolescent; Adult; Aging; Anti-Infective Agents; Epididymitis; Humans; Male; Middle A | 1987 |
[Treatment with ofloxacin (RU 43280) of uncomplicated bacterial urethritis in males].
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Gonorrhea; Humans; Male; | 1986 |